Management ChangeApr 23, 2026, 07:33 AM
Helus Pharma Adds Dr. Robert Langer & Dr. Stephen Brannan to SAB
AI Summary
Helus Pharma (Cybin Inc.) announced the appointment of Dr. Robert Langer and Dr. Stephen Brannan to its Scientific Advisory Board. These globally recognized leaders in translational science and clinical development will support the company's commitment to disciplined drug development and scientific rigor. Their expertise is expected to strengthen the scientific foundation as Helus Pharma advances its novel serotonergic agonists, including HLP003 for major depressive disorder and HLP004 for generalized anxiety disorder.
Key Highlights
- Dr. Robert Langer, a biotech leader with over 1,500 patents, joins the Scientific Advisory Board.
- Dr. Stephen Brannan, former CMO of Karuna Pharmaceuticals, also appointed to the SAB.
- The additions aim to strengthen the scientific foundation for pipeline advancement.
- New members will support HLP003 for MDD and HLP004 for GAD development.
- Dr. Langer has founded over 40 biotechnology companies, including Moderna.
Price Impact
More from HELP